Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Immuno Cure appoints new CFO 2022-11-01 20:18
Hummingbird Bioscience to Attend the Credit Suisse 31st Annual Healthcare Conference 2022-11-01 20:00
Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis 2022-11-01 19:40
Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company 2022-11-01 19:00
GenScript Supported Nasal Spray Development for COVID-19 Protection with GMP-grade Antibodies and Subsequently Planned for Long-Term Collaboration with Biogenexis 2022-11-01 11:39
CARsgen Appoints Dr. Sylvie Peltier as Senior Vice President of Global Regulatory Affairs 2022-10-31 21:30
Gracell Biotechnologies to Report Third Quarter 2022 Financials on Monday, November 14, 2022 2022-10-31 21:00
Antengene Receives U.S. FDA Clearance of IND Application for Phase I Trial of Small Molecule ERK1/2 Inhibitor ATG-017 in Patients with Advanced Solid Tumors 2022-10-31 20:22
EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine 2022-10-31 20:00
BRONCUS'S DISPOSABLE NEBULIZING MICRO-CATHETER FOR ENDOSCOPE WAS APPROVED FOR MARKETING IN CHINA AND ITS APPLICATIONS IN DRUG-DEVICE COMBINATION WILL BE BROADENED 2022-10-31 16:07
Akeso Announces Oral Presentation of Ivonescimab (PD-1/VEGF Bi-Specific) in First-line Treatment of ES-SCLC on ACLC 2022 2022-10-31 08:40
GenesisCare and PreludeDx(TM) present compelling Australian-first DCISionRT Study Interim Analysis during Breast Cancer Awareness Month 45% change in treatment recommendations when using DCISionRT 2022-10-31 05:00
Hinova Disclosed the Preclinical Results of HP518 (Oral AR PROTAC) at the 5th Annual TPD Summit 2022-10-29 05:30
Nuevocor to Present Pre-clinical Data on its Gene Therapy Candidate for LMNA Dilated Cardiomyopathy at American Heart Association Scientific Sessions 2022 2022-10-28 22:30
LISCure Biosciences Announces Oral Presentation of New Drug Candidate for NASH at Upcoming AASLD The Liver Meeting 2022 2022-10-28 21:00
Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib 2022-10-28 13:00
Acceptance Of The Application For Clinical Trial Of Recbio Novel Adjuvanted Recombinant Quadrivalent HPV Vaccine 2022-10-28 11:10
Sciwind Biosciences Announces Positive Interim Results from Ongoing Phase 2b Clinical Trial of XW003 (Ecnoglutide) in Patients with Obesity 2022-10-28 08:00
NDA for New Second-Line Indication of CAR T-Cell Therapy Product YIKAIDA (Axicabtagene Ciloleucel Injection) Approved for CDE Review 2022-10-28 01:37
Life sciences industry's highest achievers celebrated at prestigious Awards ceremony 2022-10-27 22:39
1 145 146 147 148 149 453